Abstract:Abstract Introduction/Objective Changing blood tube suppliers is a complex process that requires systematic validation. It can serve to expand a laboratory’s options during a supply shortage, and can lead to cost savings. Just prior to the pandemic, our laboratory underwent a large-scale conversion of blood tube suppliers after successful validation of serum, plasma, and whole blood tubes for blood bank, chemistry, immunology, hematology, coagulation, molecular diagnostics, and flow cytometry. Methods/Case Report First, we designed a patient consent form for collecting extra blood samples. Per CLSI standards, validation of blood tubes is needed for each testing methodology but not for each analyte. Hence, we selected high-impact assays to represent each testing methodology used by our instrument platforms. We designed comparison studies to test the new blood tubes for result accuracy, precision and specimen stability that covered an assay’s reportable range. Allowable error limits were set based on Westgard and CAP guidelines. Spiked specimens were used when positive patient samples were not feasible. We also took the opportunity to optimize the blood tube sizes, e.g., converting the lavender-top tubes from 2 ml (vendor A) to 3 ml (vendor B). We then confirmed with our reference labs the acceptability of the new vendor’s products, and administered an electronic survey to solicit staff feedback. Finally, we coordinated supply chain, formulary changes and test catalog updates. Results (if a Case Study enter NA) Data analyses showed 100% acceptable performance of the new supplier’s blood tubes. The survey showed that our phlebotomists supported the new products, citing their ease of use and good vacuum. Our hematology technologists provided favorable feedback on the larger lavender-top tubes that reduced the number of insufficient samples. On the economic front, this supplier conversion has yielded a 26% cost savings. Conclusion To our knowledge, our study is the most comprehensive of all blood collection device comparison analyses published. Our validation strategies that were designed to comply with best practice standards have led to our confidence in the interchangeability of the new and old blood tube products. This initiative serves to elucidate a protocol to add vendor options that can be replicated by other laboratories to mitigate blood tube supply shortages and backorders. It has helped us control supply costs without compromising quality.

A 5-step root cause analysis model for test overutilization: A study on its application to plasma transferrin testing

Optimizing red blood cell transfusion practices in the intensive care unit: a multi-phased health technology reassessment

Evaluating the Crossmatch-to-Transfusion Ratio as a Tool for Analyzing and Optimizing Blood Bank Resource Utilization: A Retrospective Observational Study

Analyzing RBC Transfusion Practices Using Quality Indicators: A Retrospective Transfusion Audit

Effect of laboratory testing guidelines on the utilization of tests and order entries in a surgical intensive care unit

Effective stewardship strategies to enhance appropriateness of refer-out test requests in a Canadian tertiary centre laboratory

Teaching root cause analysis in healthcare management with Grey's Anatomy

How do experts determine where to intervene on test ordering? An interview study

Reducing Unnecessary Transfusions of RBCs in Inpatients Admitted Across Niagara Health Community Hospitals

Correlation of the Transfusion Camp knowledge assessment test with clinical transfusion practice

Audit-based corrective and preventive actions to reduce wastage of blood components at a single blood center: A quality improvement study

Interventions to improve appropriateness of laboratory testing in the intensive care unit: a narrative review

Application of root cause analysis in inadequate communication in adjusting rate of intravenous infusion pump

Applying Best Practice to Converting Blood Collection Tube Suppliers: Overcoming Laboratory Supply Shortages

Analysis of a 5-year, evidenced-based, rational blood utilisation project in a South African regional hospital

A Multicenter Before-After Study on Reducing Unnecessary Diagnostics by Changing the Attitude of Caregivers: Protocol for the RODEO Project

Auditing plasma transfusion in intensive care: Use of decision time interval analysis

Using Quality Improvement to Optimize Blood Product Utilization in a Pediatric Cardiac Catheterization Laboratory

Promoting improved utilization of laboratory testing through changes in an electronic medical record: experience at an academic medical center

Targeting repetitive laboratory testing with electronic health records-embedded predictive decision support: A pre-implementation study

Validation of a New Method to Automatically Select Cases With Intraoperative Red Blood Cell Transfusion for Audit